Ep. 60 - Public opinions on Wegovy and other weight loss drugs

The FLATLINING Podcast from Fulcrum Strategies

Matthew Handley and Ron Howrigon discuss the ongoing relevance of COVID, the cost of weight loss drugs in the US, and public opinion on prescription weight loss drugs. Key highlights

• COVID still matters, especially for those at risk

• The cost of weight loss drugs in the US compared to other countries

• The need for a free market economy in healthcare

• Public opinion on prescription weight loss drugs

• The potential impact of covering weight loss drugs under insurance

Resources mentioned

• Health System Tracker - How do prices of drugs for weight loss in the U.S. compare to peer nations’ prices?

• Kaiser Family Foundation - KFF Health Tracking Poll July 2023: The Public’s Views Of New Prescription Weight Loss Drugs And Prescription Drug Costs

Facts

• COVID can still be severe for at-risk populations

• Vaccines can help prevent severe symptoms

• The US pays more for weight loss drugs compared to other countries

• The prevalence of obesity is high in the US

• The cost of covering weight loss drugs for all Americans would be significant

Action steps

• Stay informed about the ongoing impact of COVID

• Consider the cost of weight loss drugs and explore alternative options

• Share your opinion on prescription weight loss drugs

• Advocate for healthcare policies that promote a free market economy

Listener challenge: Reflect on your own opinion about prescription weight loss drugs and consider the potential impact of covering them under insurance.

• Matthew Handley on X

• Ron Howrigon on X

Subscribe to the Flatlining Podcast to never miss an episode and join the conversation about important healthcare topics.